Induced pluripotent stem cells in the study of neurological diseases

Stem Cell Research and Therapy

Volumn 2, Issue 5, 2011, Pages

  Saporta, Mario A ^a,b   Grskovic, Marica ^a   Dimos, John T ^a  

^a IPierian Inc   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2; SURVIVAL MOTOR NEURON PROTEIN 1; SURVIVAL MOTOR NEURON PROTEIN 2;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BECKER MUSCULAR DYSTROPHY; CELL DIFFERENTIATION; CELL LINEAGE; DUCHENNE MUSCULAR DYSTROPHY; DYSAUTONOMIA; GENE; HUMAN; IKBKAP GENE; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PLURIPOTENT STEM CELL; RETT SYNDROME; SCHIZOPHRENIA; SMN1 GENE; SMN2 GENE; SPINAL MUSCULAR ATROPHY; CYTOLOGY; DRUG SCREENING; GLIA; METABOLISM; NERVE CELL; REVIEW; TRANSPLANTATION;

CELL DIFFERENTIATION; CELL LINEAGE; DRUG EVALUATION, PRECLINICAL; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NERVOUS SYSTEM DISEASES; NEUROGLIA; NEURONS;

EID: 84863360741     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt78     Document Type: Article

References (57)

1. World Health Organization: Neurological Disorders: Public Health Challenge. Geneva: World Health Organization; 2006.
2. World Health Organization: Global Burden of Disease and Risk Factors. 2004 Update. Geneva: World Health Organization; 2008.
3. Nagai M, Aoki M, Miyoshi I, Kato M, Pasinelli P, Kasai N, Brown RH, Jr, Itoyama Y: Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J Neurosci 2001, 21: 9246-9254.
4. Niemann S, Sereda MW, Rossner M, Stewart H, Suter U, Meinck HM, Griffiths IR, Nave KA: The 'CMT rat': peripheral neuropathy and dysmyelination caused by transgenic overexpression of PMP22. Ann N Y Acad Sci 1999, 883: 254-261.
5. Robaglia-Schlupp A, Pizant J, Norreel JC, Passage E, Saberan-Djoneidi D, Ansaldi JL, Vinay L, Figarella-Branger D, Levy N, Clarac F, Cau P, Pellissier JF, Fontes M: PMP22 overexpression causes dysmyelination in mice. Brain 2002, 125: 2213-2221.
6. Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M, Le Paslier D, Frezal J, Cohen D, Weissenbach J, Munnich A, Melki J: Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995, 80: 155-165.
7. Monani UR, Coovert DD, Burghes AH: Animal models of spinal muscular atrophy. Hum Mol Genet 2000, 9: 2451-2457.
8. Hao LT, Burghes AH, Beattie CE: Generation and characterization of a zebrafish model of SMA carrying the human SMN2 gene. Mol Neurodegener 6: 24-32.
9. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126: 663-676.
10. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131: 861-872.
11. Lewitzky M, Yamanaka S: Reprogramming somatic cells towards pluripotency by defined factors. Curr Opin Biotechnol 2007, 18: 467-473.
12. Stadtfeld M, Hochedlinger K: Induced pluripotency: history, mechanisms, and applications. Genes Dev 2010, 24: 2239-2263.
13. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier G, Leibel R, Goland R, Wichterle H, Henderson CE, Eggan K: Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008, 321: 1218-1221.
14. Ebert AD, Yu J, Rose FF, Jr, Mattis VB, Lorson CL, Thomson JA, Svendsen CN: Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009, 457: 277-280.
15. Marchetto MC, Carromeu C, Acab A, Yu D, Yeo GW, Mu Y, Chen G, Gage FH, Muotri AR: A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010, 143: 527-539.
16. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A, Cooper O, Mitalipova M, Isacson O, Jaenisch R: Parkinson's disease patientderived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009, 136: 964-977.
17. Swistowski A, Peng J, Liu Q, Mali P, Rao MS, Cheng L, Zeng X: Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells 2010, 28: 1893-1904.
18. Ogawa S, Tokumoto Y, Miyake J, Nagamune T: Immunopanning selection of A2B5-positive cells increased the differentiation efficiency of induced pluripotent stem cells into oligodendrocytes. Neurosci Lett 2011, 489: 79-83.
19. Ziegler L, Grigoryan S, Yang IH, Thakor NV, Goldstein RS: Efficient generation of Schwann cells from human embryonic stem cell-derived neurospheres. Stem Cell Rev 2011, 7: 394-403.
20. Lee G, Chambers SM, Tomishima MJ, Studer L: Derivation of neural crest cells from human pluripotent stem cells. Nat Protoc 2010, 5: 688-701.
21. Liu Y, Zhang SC: Human stem cells as a model of motoneuron development and diseases. Ann N Y Acad Sci 2010, 1198: 192-200.
22. Malgrange B, Borgs L, Grobarczyk B, Purnelle A, Ernst P, Moonen G, Nguyen L: Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms. Cell Mol Life Sci 2010, 68: 635-649.
23. Nizzardo M, Simone C, Falcone M, Locatelli F, Riboldi G, Comi GP, Corti S: Human motor neuron generation from embryonic stem cells and induced pluripotent stem cells. Cell Mol Life Sci 2010, 67: 3837-3847.
24. Karumbayaram S, Novitch BG, Patterson M, Umbach JA, Richter L, Lindgren A, Conway AE, Clark AT, Goldman SA, Plath K, Wiedau-Pazos M, Kornblum HI, Lowry WE: Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells 2009, 27: 806-811.
25. Lunn MR, Wang CH: Spinal muscular atrophy. Lancet 2008, 371: 2120-2133.
26. Axelrod FB, Gold-von Simson G: Hereditary sensory and autonomic neuropathies: types II, III, and IV. Orphanet J Rare Dis 2007, 2: 39.
27. Slaugenhaupt SA, Blumenfeld A, Gill SP, Leyne M, Mull J, Cuajungco MP, Liebert CB, Chadwick B, Idelson M, Reznik L, Robbins C, Makalowska I, Brownstein M, Krappmann D, Scheidereit C, Maayan C, Axelrod FB, Gusella JF: Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet 2001, 68: 598-605.
28. Close P, Hawkes N, Cornez I, Creppe C, Lambert CA, Rogister B, Siebenlist U, Merville MP, Slaugenhaupt SA, Bours V, Svejstrup JQ, Chariot A: Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia. Mol Cell 2006, 22: 521-531.
29. Lee G, Papapetrou EP, Kim H, Chambers SM, Tomishima MJ, Fasano CA, Ganat YM, Menon J, Shimizu F, Viale A, Tabar V, Sadelain M, Studer L: Modelling pathogenesis and treatment of familial dysautonomia using patientspecific iPSCs. Nature 2009, 461: 402-406.
30. Hagberg B: Rett's syndrome: prevalence and impact on progressive severe mental retardation in girls. Acta Paediatr Scand 1985, 74: 405-408.
31. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY: Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl- CpG-binding protein 2. Nat Genet 1999, 23: 185-188.
32. Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY: MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008, 320: 1224-1229.
33. Muotri AR, Marchetto MC, Coufal NG, Oefner R, Yeo G, Nakashima K, Gage FH: L1 retrotransposition in neurons is modulated by MeCP2. Nature 2010, 468: 443-446.
34. Boulting GL, Kiskinis E, Croft GF, Amoroso MW, Oakley DH, Wainger BJ, Williams DJ, Kahler DJ, Yamaki M, Davidow L, Rodolfa CT, Dimos JT, Mikkilineni S, MacDermott AB, Woolf CJ, Henderson CE, Wichterle H, Eggan K: A functionally characterized test set of human induced pluripotent stem cells. Nat Biotechnol 2011, 29: 279-286.
35. Schrag A: Epidemiology of movement disorders. In Parkinson's Disease and Movement Disorders. 5th edition. Edited by Tolosa JJaE. Philadelphia: Lippincott Williams & Wilkins; 2007: 50-66.
36. Chaudhuri KR, Healy DG, Schapira AH: Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006, 5: 235-245.
37. Hargus G, Cooper O, Deleidi M, Levy A, Lee K, Marlow E, Yow A, Soldner F, Hockemeyer D, Hallett PJ, Osborn T, Jaenisch R, Isacson O: Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci U S A 2010, 107: 15921-15926.
38. Nguyen HN, Byers B, Cord B, Shcheglovitov A, Byrne J, Gujar P, Kee K, Schule B, Dolmetsch RE, Langston W, Palmer TD, Pera RR: LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 2011, 8: 267-280.
39. Ben-Hur T, Idelson M, Khaner H, Pera M, Reinhartz E, Itzik A, Reubinoff BE: Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells 2004, 22: 1246-1255.
40. Yang D, Zhang ZJ, Oldenburg M, Ayala M, Zhang SC: Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats. Stem Cells 2008, 26: 55-63.
41. Sonntag KC, Pruszak J, Yoshizaki T, van Arensbergen J, Sanchez-Pernaute R, Isacson O: Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells 2007, 25: 411-418.
42. Seibler P, Graziotto J, Jeong H, Simunovic F, Klein C, Krainc D: Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J Neurosci 2011, 31: 5970-5976.
43. van Os J, Kapur S: Schizophrenia. Lancet 2009, 374: 635-645.
44. Wu EQ, Birnbaum HG, Shi L, Ball DE, Kessler RC, Moulis M, Aggarwal J: The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry 2005, 66: 1122-1129.
45. Sullivan PF, Kendler KS, Neale MC: Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003, 60: 1187-1192.
46. Nestler EJ, Hyman SE: Animal models of neuropsychiatric disorders. Nat Neurosci 2010, 13: 1161-1169.
47. Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, Sangar S, Li Y, Mu Y, Chen G, Yu D, McCarthy S, Sebat J, Gage FH: Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011, 473: 221-225.
48. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ: Disease-specific induced pluripotent stem cells. Cell 2008, 134: 877-886.
49. Kazuki Y, Hiratsuka M, Takiguchi M, Osaki M, Kajitani N, Hoshiya H, Hiramatsu K, Yoshino T, Kazuki K, Ishihara C, Takehara S, Higaki K, Nakagawa M, Takahashi K, Yamanaka S, Oshimura M: Complete genetic correction of iPS cells from Duchenne muscular dystrophy. Mol Ther 2010, 18: 386-393.
50. Zhang N, An MC, Montoro D, Ellerby LM: Characterization of human Huntington's disease cell model from induced pluripotent stem cells. PLoS Curr 2010, 2: RRN1193.
51. Chamberlain SJ, Chen PF, Ng KY, Bourgois-Rocha F, Lemtiri-Chlieh F, Levine ES, Lalande M: Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes. Proc Natl Acad Sci U S A 2010, 107: 17668-17673.
52. Yang J, Cai J, Zhang Y, Wang X, Li W, Xu J, Li F, Guo X, Deng K, Zhong M, Chen Y, Lai L, Pei D, Esteban MA: Induced pluripotent stem cells can be used to model the genomic imprinting disorder Prader-Willi syndrome. J Biol Chem 2010, 285: 40303-40311.
53. Placantonakis DG, Tomishima MJ, Lafaille F, Desbordes SC, Jia F, Socci ND, Viale A, Lee H, Harrison N, Tabar V, Studer L: BAC transgenesis in human embryonic stem cells as a novel tool to define the human neural lineage. Stem Cells 2009, 27: 521-532.
54. Hockemeyer D, Soldner F, Beard C, Gao Q, Mitalipova M, DeKelver RC, Katibah GE, Amora R, Boydston EA, Zeitler B, Meng X, Miller JC, Zhang L, Rebar EJ, Gregory PD, Urnov FD, Jaenisch R: Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol 2009, 27: 851-857.
55. Khan IF, Hirata RK, Wang PR, Li Y, Kho J, Nelson A, Huo Y, Zavaljevski M, Ware C, Russell DW: Engineering of human pluripotent stem cells by AAVmediated gene targeting. Mol Ther 2010, 18: 1192-1199.
56. Urbach A, Bar-Nur O, Daley GQ, Benvenisty N: Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 2010, 6: 407-411.
57. Hotta A, Cheung AY, Farra N, Vijayaragavan K, Seguin CA, Draper JS, Pasceri P, Maksakova IA, Mager DL, Rossant J, Bhatia M, Ellis J: Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat Methods 2009, 6: 370-376.